Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygenation for patients with post-COVID-19 sequelae (Pilot study)
2021-001126-21Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxygen in post-COVID syndrome, sponsored by Medical University of Graz. Primary endpoints: Feasibility of hyperbaric oxygen therapy in Long COVID, Safety of hyperbaric oxygen therapy in Long COVID and 1 more. Started Apr 2021; status: completed.
02
Drugs
oxygen
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on 2021-001126-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001126-21.